ema

Amgen’s Kyprolis gains expanded myeloma use in Europe

https://pharmaphorum.com/transversal-categories/uk-and-europe/amgens-kyprolis-gains-expanded-myeloma-use-europe/

Brexit: could European Medicines Agency stay in London?

https://pharmaphorum.com/news/brexit-could-change-eu-drug-regulation-system/

EU regulators back blood cancer stem cell therapy

https://pharmaphorum.com/news/eu-regulators-back-blood-cancer-stem-cell-therapy/

Pharma concerned as UK votes for “Brexit”

https://pharmaphorum.com/news/pharma-concerned-as-uk-votes-for-brexit/

EU drug safety reporting system delayed

https://pharmaphorum.com/news/eu-drug-safety-reporting-system-delayed/

European safety experts review latest hepatitis C drugs

https://pharmaphorum.com/news/european-safety-experts-review-latest-hepatitis-c-drugs/

«< 6 7 8 9 10

Close in 10 seconds

Pharmaphorum.com

Search